This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Actogenix N.v., Vlaams Interuniversitair Instituut Voor Biotechnologie. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lonendegem, BE (2007)
- Lovendegem, BE (2009)
Company Filing History:
1 out of 9 
1 out of 10 Years Active: 2007-2009
Title: The Innovations of Erik René Remaut
Introduction
Erik René Remaut is a notable inventor based in Lovendegem, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for delivering therapeutic peptides. With a total of 2 patents, his work focuses on addressing gastrointestinal disorders through the use of specific bacterial strains.
Latest Patents
One of Erik René Remaut's latest patents involves the delivery of trefoil peptides. This invention relates to a microorganism, specifically a non-pathogenic, non-invasive, food-grade, gram-positive bacterial strain that delivers a trefoil peptide in vivo. The preferred trefoil peptide in this invention is TFF1. The patent outlines a method for delivering the trefoil peptide to the gastrointestinal tract by administering the bacterial strain. Additionally, it includes a pharmaceutical composition comprising the trefoil peptide delivering bacterium and methods for treating acute gastrointestinal inflammatory diseases. This includes the treatment of acute colitis and flare-ups of Crohn's disease and ulcerative colitis in humans, as well as similar gastrointestinal disorders in other animal species.
Career Highlights
Throughout his career, Erik René Remaut has worked with prominent organizations such as the Flemish Interuniversity Institute for Biotechnology and Actogenix N.V. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology significantly.
Collaborations
Erik has collaborated with notable individuals in his field, including Wolfgang Christian Hans and Lothar Steidler. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Erik René Remaut's contributions to biotechnology, particularly in the delivery of trefoil peptides, showcase his innovative spirit and dedication to improving gastrointestinal health. His work continues to influence the field and offers promising solutions for treating various gastrointestinal disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile